Syncora Holdings
Syncora is a US-based clinical trial SaaS platform, operated under Digital Auxilius, that helps research sites, sponsors, and CROs manage study startup, site activation, document control, and regulatory compliance through subscription-priced workflow modules.
- Company typePrivate
- Founded2006
- HeadquartersHamilton, Bermuda
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Syncora Holdings does
Syncora is a clinical study startup management platform delivered as a cloud-based SaaS solution, operated under parent company Digital Auxilius. The platform serves clinical research sites, pharmaceutical sponsors, and Contract Research Organizations (CROs), providing tools for site selection, activation, document management with version control, regulatory compliance, investigator tracking, and multi-site trial coordination. Core modules include Site Startup, Study Startup, File Manager, Lead Management, User Management, Site Tours, Event Scheduler, Investigator Management, and Reports/Dashboard Analytics, with regulatory features including 21 CFR Part 11-compliant electronic records and signatures, an Excel-to-CTMS data bridge, and PSV-SIV scheduling.
The platform is delivered as a web-based SaaS product accessible on desktop and mobile, with 24/7 support via email, live chat, and phone. Syncora monetizes through subscription pricing: a Teams tier at $499/month (for organizations billing up to $100K/month) and a custom Enterprise tier, with an annual commitment discount option. Distribution is primarily direct enterprise field sales anchored on a 'Book a Demo' CTA, supplemented by a free-trial self-serve channel for mid-market prospects. The company is privately held under Digital Auxilius, headquartered at 28260 Franklin Rd, Southfield, Michigan, and reports 100+ trials managed and 340+ sites onboarded. Leadership includes Founder and CEO Dr. Mazhar Jaffry, Chief Product Officer Khizar Jaffry, and Director Dr. Ashfaq Ahmed Mian.
Note on source material: the firmographics header describes Syncora Holdings as a Bermuda-domiciled, NYSE-listed (SCA) monoline financial guarantee insurer founded in 2006, whereas all other source blocks and the scraped website describe a US-based private clinical trial SaaS company. This analysis is grounded in the latter body of evidence, which is first-party and internally consistent.
Syncora Holdings firmographics
Firmographics- Name
- Syncora Holdings
- Legal name
- Syncora
- Website
- https://syncora.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Syncora is a US-based clinical trial SaaS platform, operated under Digital Auxilius, that helps research sites, sponsors, and CROs manage study startup, site activation, document control, and regulatory compliance through subscription-priced workflow modules.
- Ownership category
- akta.pro rank
Syncora Holdings industry classification
Industry- Product category
- Clinical Trial Management Software
- NAICS
- Software Publishers (513210), Computer Systems Design and Related Services (54151)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)
- akta.pro secondary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where Syncora Holdings is headquartered
LocationHeadquarters
- HQ city
- Hamilton
- HQ country
- Bermuda
Offices1 record
Markets served
Syncora Holdings business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription (Teams Plan): Monthly subscription at $499/month for Teams tier with access to Site Startup, Study Startup, Dashboard Analytics, and Lead Management features. Billed monthly with annual commitment.
- Enterprise Pricing: Custom enterprise pricing for complex clinical research needs with scalable, secure, and intelligent solutions. Includes multi-site trial management, enterprise-level security, customizable workflows, and advanced analytics.
- Annual Subscription Discount: $4800/year annual commitment option, offering savings compared to monthly billing
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Teams plan at $499/month for up to $100K billing/month with Site Startup, Study Startup, Dashboard Analytics, and Lead Management |
| Subscription | Annual | Enterprise plan with custom pricing for complex clinical research needs |
| Subscription | Annual | Annual commitment option at $4800/year |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Syncora Holdings product offering
Product offeringCore offering
Syncora provides a cloud-based SaaS platform that streamlines clinical trial study startup activities, including site selection, site activation, document management, regulatory compliance, investigator coordination, and multi-stakeholder collaboration. The platform is sold to pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites on subscription-based Teams and Enterprise pricing plans.
Product overview
Syncora is a clinical study startup management platform delivered as a unified SaaS/hybrid solution. The core Syncora Platform serves as the central hub, integrated with modules for Site Startup, Lead Management, Study Startup, File Manager, User Management, Site Tours, Event Scheduler, and Investigator Management. Additional features include Networks for vendor coordination, Virtual Tour for site visualization, 21 CFR Part 11 compliance tools, and PSV-SIV Scheduler for visit coordination. The platform offers two pricing tiers: Teams ($499/month) and Enterprise (custom quote), supporting 100+ trials managed and 340+ sites onboarded.
Differentiator
Problem solved
Functional benefit
Products and services
- Syncora Platform A cloud-based SaaS platform for clinical trial study startup management that streamlines site selection, site activation, document control, regulatory compliance, investigator coordination, lead management, and multi-stakeholder collaboration for pharmaceutical sponsors, CROs, and clinical research sites. Delivered as a subscription to pharmaceutical sponsors, CROs, and clinical research sites via Teams and Enterprise pricing plans.
Quantifiable outcome
- 62.5% reduction in average site activation time (from 120 days to 45 days in oncology trial case study)
- +7 more outcomes
Companies that use Syncora Holdings
Customer profileNamed customers10 records
Segments10 records
Ideal customer profiles3 records
Syncora Holdings technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature15 records
Syncora Holdings partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SCRS (Site Choice and Retention Solutions)coreSyncora was a Performance Sponsor of the SCRS Global Site Solutions Summit 2025 held in Orlando, Florida. The summit brings together sites, sponsors, CROs, and solution providers to tackle clinical trial challenges. Syncora participated at Booth #901 to engage with industry professionals about their study startup management solutions.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Syncora Holdings competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA's Orchestrated Clinical Trials suite includes site startup, CTMS, and site management offerings that compete for the same sponsor/CRO budget Syncora targets, with the added advantage of IQVIA's CRO services.
- Veeva Systems: Veeva's Vault CTMS and Vault eTMF compete in clinical trial site and document management with a much broader life-sciences SaaS portfolio; the same enterprise buyers (sponsors, CROs) that Syncora targets are Veeva's core customers.
- Oracle Clinical One: Oracle's Clinical One platform unifies CTMS, EDC, and eTMF for sponsors and CROs and competes for the same clinical operations workflow footprint that Syncora targets, especially around site startup and study conduct.
- Medidata (Dassault Systèmes): Medidata's Rave platform spans CTMS, EDC, eCOA, and eTMF used by most large sponsors and CROs; it competes with Syncora for the clinical operations budget, particularly in site activation and study startup workflows.
- Signant Health: Signant provides eCOA, eConsent, and clinical supply solutions that increasingly overlap with site startup and study conduct workflows targeted by Syncora, especially for sponsor-led studies.
- WCG: WCG provides IRB, IBC, technology, and consulting services for clinical research sites and sponsors — overlapping Syncora's regulatory, site start-up, and compliance value proposition through a different operating model.
Emerging players
- Castor: Castor offers a clinical trial data platform (EDC, ePRO, eConsent) with workflow tools aimed at sponsors, CROs, and sites — a comparable emerging SaaS peer competing for similar mid-market clinical research buyers.
Direct peers
- Florence Healthcare: Florence's eBinders/eISF and Trial Site Engagement platform manage site regulatory documents, file workflows, and study startup tasks — a closely comparable offering to Syncora's File Manager and Site Startup modules.
- RealTime Software Solutions: RealTime provides CTMS, eRegulatory, and site-management software widely used by independent research sites and site networks — directly competing with Syncora's site-side startup and compliance modules at similar price points.
- Advarra: Advarra offers IRB, IBC, and clinical technology solutions (including its own CTMS-adjacent workflow tooling) for sites, sponsors, and CROs — directly overlapping Syncora's regulatory and study-startup workflow value proposition.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Syncora Holdings social profiles
Digital presenceSyncora Holdings financial estimates
Financial estimateRevenue estimate
Valuation estimate
Syncora Holdings leadership team
Management profileNumber of profiles
Profiles3 records
Syncora Holdings funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Syncora Holdings M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Syncora Holdings
What does Syncora Holdings do?
Syncora provides a cloud-based SaaS platform that streamlines clinical trial study startup activities, including site selection, site activation, document management, regulatory compliance, investigator coordination, and multi-stakeholder collaboration. The platform is sold to pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites on subscription-based Teams and Enterprise pricing plans.
Is Syncora Holdings a public or private company?
Syncora Holdings is a private company. It is classified as corporate owned and is currently operating.
When was Syncora Holdings founded?
Syncora Holdings was founded in 2006. It employs 1 to 10 people.
Where is Syncora Holdings based?
Syncora Holdings is headquartered in Hamilton, Bermuda.
How does Syncora Holdings make money?
Three revenue lines are on record. SaaS Subscription (Teams Plan) is the primary driver. The others are enterprise Pricing and annual Subscription Discount.
Who are Syncora Holdings's main competitors?
Broad incumbents on record are IQVIA, Veeva Systems, Oracle Clinical One, Medidata (Dassault Systèmes), Signant Health and WCG. Castor is listed as an emerging player. Direct peers are Florence Healthcare, RealTime Software Solutions and Advarra.
Does Syncora Holdings have an API?
No public API is recorded for Syncora Holdings.
What industry is Syncora Holdings in?
Syncora Holdings's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGACAC, Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 513210 and its SIC code is 7372.